Q2 2025 Narayana Hrudayalaya Ltd Earnings Call Transcript
Key Points
- Narayana Hrudayalaya Ltd (BOM:539551) has successfully commissioned the outpatient facility of its new hospital, with plans to fully operationalize the entire hospital in the next four weeks.
- The company has earmarked significant CapEx towards greenfield and inorganic growth opportunities, indicating a strong focus on expansion.
- The new hospital cluster in India has shown strong revenue growth of around 13% year-on-year, with revenue crossing INR 130 crores for the quarter.
- Narayana Hrudayalaya Ltd (BOM:539551) is optimistic about reducing the margin dilution period from six to eight quarters to four to five quarters for its Cayman facility.
- The company is focusing on high-end procedures and complex surgeries, which are expected to continue contributing positively to revenue growth.
- The new hospital in Cayman is incurring significant costs, with 75% to 80% of costs already on the books, while revenue ramp-up is still in the early stages.
- There has been a decline in outpatient numbers and revenue per patient in the Cayman facility, attributed to factors like hurricanes and compliance obligations.
- The company faces challenges in the Bangladesh market due to visa restrictions, impacting international patient footfall and revenue.
- Narayana Hrudayalaya Ltd (BOM:539551) has experienced a decline in discharge and outpatient volumes on a year-on-year basis.
- The company is incurring a cash burn in its Integrated Care and Insurance business, with an EBITDA burn of around INR 25 crores for the first half of the year.
Hello, everyone. My name is Nishant Singh. I head the IR function at Narayana Hrudayalaya. I welcome you all to the quarter two FY25 earnings call for the company. To discuss our performance and address all your queries today, we also have with us Mr. Viren Shetty, our Vice Chairman; Dr. Emmanuel Rupert, CEO, MD; Mrs. Sandhya Jayaraman, our Group CFO; Mr. Vinkatesh; our Group CEO; Dr. Anesh Shetty, MD of our Cayman business; Mr. Ravi Vishwanath, CEO of (inaudible); and Vivek Agarwal, Senior Manager in the IR function.
As usual, before we proceed with this call, we would like to remind everyone that the call is being recorded, and the transcript of the same shall be made available on our website as well as on the Stock Exchange later. I would also like to remind you that everything that is being said on this call that reflects any outlook for the future or which can be construed as a forward-looking statement must be viewed in conjunction with the uncertainties and the risks that we face.
With that now, we would like to start the Q
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
